EUVIMEDEUVIMED entdecken
Crossref

Myeloperoxidase gene variation and coronary flow reserve in young healthy men

Riikka Mäkelä, Reijo Laaksonen, Tuula Janatuinen, Risto Vesalainen, Pirjo Nuutila, Olli Jaakkola, Juhani Knuuti, Terho Lehtimäki

Journal of Biomedical Science · 2004-01 · 11 (1) · 59-64

DOI: 10.1007/bf02256549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Science, 2004-01. Verfasst von Riikka Mäkelä und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry, Laboratory of Atherosclerosis, Tampere University Hospital and University of Tampere Medical School, FinnMedi 2, 3r…. Hauptthemen laut MEDLINE: Genetic Variation. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammation may lead to endothelial dysfunction, which manifests as an impaired coronary reactivity. Impairment in coronary flow reserve (CFR), preceding the clinical symptoms of coronary artery disease, can be measured noninvasively by positron emission tomography. Myeloperoxidase (MPO) is an oxidative enzyme present in phagocytes and atherosclerotic lesions. The MPO gene has a promoter polymorphism (-463G/A) which affects gene transcription. Whether these variants associate with coronary artery function is not known. Myocardial blood flow at rest and during adenosine-induced hyperemia was assessed in 49 healthy young men with normal or slightly elevated serum total cholesterol. These subjects were divided into high (G/G) and low (A/G, A/A) MPO expression groups and effect of MPO genotype on myocardial blood flow was evaluated. We found a significant difference between MPO genotypes in CFR after adjusting for age, body mass index, smoking and family history of cardiovascular disease (p = 0.019). Men with G/G genotype had 18.1% lower CFR than subjects with low-expression genotypes (A/G and A/A). This was due to an 11.5% lower adenosine-stimulated flow of the G/G genotype carriers (p = 0.049). These findings provide evidence that MPO polymorphism is associated with coronary artery reactivity. However, the number of individuals investigated was low and our observation should be confirmed by a larger number of subjects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic VariationAdenosineAdultCholesterolCoronary CirculationGenotypeHumansLipoproteins, LDLMaleOxidation-ReductionPeroxidasePromoter Regions, GeneticRegional Blood FlowTomography, Emission-Computed

Substanzen

Lipoproteins, LDLCholesterolPeroxidaseAdenosine

Autor:innen und Institutionen

  • Department of Clinical Chemistry, Laboratory of Atherosclerosis, Tampere University Hospital and University of Tampere Medical School, FinnMedi 2, 3rd floor, FI-33521 Tampere, Finland.

Zitieren

APA

Mäkelä, R., Laaksonen, R., Janatuinen, T., Vesalainen, R., Nuutila, P., Jaakkola, O., Knuuti, J., & Lehtimäki, T. (2004). Myeloperoxidase gene variation and coronary flow reserve in young healthy men. Journal of Biomedical Science, 11(1), 59-64. https://doi.org/10.1007/bf02256549

Vancouver

Mäkelä R, Laaksonen R, Janatuinen T, Vesalainen R, Nuutila P, Jaakkola O, et al. Myeloperoxidase gene variation and coronary flow reserve in young healthy men. Journal of Biomedical Science. 2004;11(1):59-64. doi:10.1007/bf02256549

BibTeX
@article{Mkel2004,
  author = {Mäkelä, Riikka and Laaksonen, Reijo and Janatuinen, Tuula and Vesalainen, Risto and Nuutila, Pirjo and Jaakkola, Olli and Knuuti, Juhani and Lehtimäki, Terho},
  title = {Myeloperoxidase gene variation and coronary flow reserve in young healthy men},
  journal = {Journal of Biomedical Science},
  year = {2004},
  volume = {11},
  number = {1},
  pages = {59--64},
  doi = {10.1007/bf02256549}
}
Kostenlos starten →